Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
01 1Interquim, S.A. de C.V.
02 1Pharmatory Oy
01 1ATIPAMEZOLE HYDROCHLORIDE
02 1Atipamezole Hydrochloride
01 1Finland
02 1Spain
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
NDC Package Code : 40074-0002
Start Marketing Date : 2015-02-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71362-003
Start Marketing Date : 2022-11-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Atipamezole Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atipamezole Hydrochloride, including repackagers and relabelers. The FDA regulates Atipamezole Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atipamezole Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atipamezole Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atipamezole Hydrochloride supplier is an individual or a company that provides Atipamezole Hydrochloride active pharmaceutical ingredient (API) or Atipamezole Hydrochloride finished formulations upon request. The Atipamezole Hydrochloride suppliers may include Atipamezole Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Atipamezole Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atipamezole Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atipamezole Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atipamezole Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atipamezole Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atipamezole Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atipamezole Hydrochloride suppliers with NDC on PharmaCompass.
We have 2 companies offering Atipamezole Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
